Mechanical complications after an acute myocardial infarction are life-threatening events that typically occur within the first week following the insult. While their incidence has decreased significantly in the
Stress cardiomyopathy, also commonly known as Takotsubo cardiomyopathy or “Broken Heart Syndrome,” is a temporary heart condition that often mimics a heart attack but is triggered by severe
Cardiorenal Syndrome (CRS) describes the complex, bidirectional pathological interaction between the heart and the kidneys. In this relationship, dysfunction in one organ frequently initiates or exacerbates dysfunction in
Percutaneous mitral valve repair (PMVR) is a minimally invasive procedure used to treat mitral regurgitation (MR)—a condition where the heart’s mitral valve doesn’t close tightly, causing blood to
P2Y12 receptor antagonists are a critical class of antiplatelet medications primarily used in the management of Acute Coronary Syndromes (ACS) and during Percutaneous Coronary Intervention (PCI). They work
Managing the cardiotoxic effects of Anthracyclines (e.g., Doxorubicin) and Trastuzumab is a cornerstone of modern cardio-oncology. While both can lead to heart failure, their mechanisms and “reversibility” profiles
Imagine that you’re in the ER at 0:05. The monitor alarms. You see ST-segment elevation in the precordial leads. Your first instinct? Activate the cath lab. But wait…
Distinguishing Ventricular Tachycardia (VT) from Supraventricular Tachycardia with aberrancy (SVT-A) is a critical skill in cardiology. When faced with a Regular Wide Complex Tachycardia (WCT), the three important
This is a foundational topic in clinical cardiology. When approaching narrow complex tachycardia (NCT)—defined as a QRS duration <120 ms with a rate >100 bpm—the diagnostic goal is
Mastering the interpretation of a 12-lead ECG in the context of Congenital Heart Disease requires moving beyond standard adult “ischemia-centric” thinking. In CHD, the ECG is a map
